Shares of Quantinuum Inc. (NASDAQ:QNT – Get Free Report) dropped 8.2% on Monday . The stock traded as low as $64.55 and last traded at $64.64. 666,721 shares traded hands during mid-day trading, a decline of 82% from the average daily volume of 3,752,017 shares. The stock had previously closed at $70.45.
Wall Street Analyst Weigh In
A number of equities analysts have recently commented on the stock. Zacks Research raised shares of Quantinuum to a “hold” rating in a report on Tuesday, June 30th. Wall Street Zen lowered shares of Quantinuum from a “hold” rating to a “sell” rating in a research note on Saturday, July 4th. TD Cowen initiated coverage on shares of Quantinuum in a report on Monday, June 29th. They issued a “buy” rating for the company. Cantor Fitzgerald began coverage on shares of Quantinuum in a research note on Monday, June 29th. They set an “overweight” rating and a $90.00 target price for the company. Finally, UBS Group assumed coverage on Quantinuum in a report on Monday, June 29th. They set a “buy” rating and a $93.00 price target on the stock. Twelve investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $98.75.
Get Our Latest Stock Report on QNT
Quantinuum Price Performance
Insider Transactions at Quantinuum
Quantinuum Company Profile
Quantinuum is a quantum computing company focused on developing hardware and software for commercial and scientific applications. The company provides access to its quantum systems, along with software tools and services designed to help customers explore use cases in areas such as optimization, materials science, chemistry, cybersecurity, and machine learning.
The company was formed through the combination of Honeywell Quantum Solutions and Cambridge Quantum in 2021. Quantinuum operates internationally and serves a range of customers across enterprise, government, and research markets.
Featured Stories
- Five stocks we like better than Quantinuum
- Why Welltower’s Growth Story Might Outrun Its Rich Valuation
- One Short- and One Long-Term ETF for Quantum Computing Bulls
- The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions
- Why Micron Is Doubling Down While the HBM Shortage Persists
Receive News & Ratings for Quantinuum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantinuum and related companies with MarketBeat.com's FREE daily email newsletter.
